H. Brauch

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
20250 citationsauthor #35
Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells
20250 citationsauthor #15
Supplementation of Tamoxifen with low-dose Endoxifen in breast cancer patients with impaired tamoxifen metabolism (TAMENDOX): a randomized controlled phase 1/2 trial.
20251 citationsauthor #17
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
20251 citationsauthor #74
Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer
20255 citationsauthor #27
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance
20249 citationsauthor #8
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction
20246 citationsauthor #25
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
20249 citationsauthor #25
Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort
20242 citationsauthor #16
Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations
202319 citationsauthor #30
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
20230 citationsauthor #10
The impact of coding germline variants on contralateral breast cancer risk and survival
202320 citationsauthor #13
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer
20235 citationsauthor #46
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
20235 citationsauthor #10
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
20238 citationsauthor #21
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
202220 citationsauthor #25
(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study
20227 citationsauthor #14
Abstract P1-07-08: Endoxifen predicts early recurrence in breast cancer: A Brazilian prospective study
20220 citationsauthor #12
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
20222 citationsauthor #25
DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy
202241 citationsauthor #12
TAMOXIFEN ADJUVANT INTERFERERS STUDY (TAIS STUDY): AN EXPLORATIVE ANALYSIS OF (Z)- ENDOXIFEN AND EARLY RECURRENCE OF BREAST CANCER IN A PROSPECTIVE BRAZILIAN STUDY
20220 citationsauthor #8
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
20218 citationsauthor #28
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
202116 citationsauthor #23
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
20210 citationsauthor #8
OP-JNCI200057 329..337
20210 citationsauthor #27
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
202131 citationsauthor #33
Epigenetic Quanti cation of Circulating Immune Cells in Peripheral Blood of Triple-Negative Breast Cancer patients
20211 citationsauthor #5
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
20213 citationsauthor #8
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
20210 citationsauthor #33
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
202114 citationsauthor #145
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
2021795 citationsauthor #47
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
20200 citationsauthor #37
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
20208 citationsauthor #11
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations
20208 citationsauthor #16
Obesity alters endoxifen plasma levels in young breast cancer patients: A pharmacometric simulation approach.
202024 citationsauthor #6
No association of polymorphisms in the cell polarity gene with breast cancer risk
20200 citationsauthor #7
Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical models
202023 citationsauthor #14
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
20205 citationsauthor #27
Abstract P2-11-12: The influences of adherence to tamoxifen and CYP2D6 pharmacogenetics on plasma concentrations of the active metabolite (Z)-endoxifen in breast cancer
20200 citationsauthor #14
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor–Positive Breast Cancer Patients
202018 citationsauthor #18
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
202052 citationsauthor #25
Abstract 144: Genome-wide DNA methylation changes in AI-resistant breast cancer models during E2-treatment
20200 citationsauthor #9
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
202034 citationsauthor #20
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
202039 citationsauthor #35
Title: Obesity alters endoxifen plasma levels in young breast cancer patients: A pharmacometric simulation approach. Authors:
20200 citationsauthor #7
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
20208 citationsauthor #12
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
202053 citationsauthor #26
Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer.
201929 citationsauthor #9
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
201937 citationsauthor #70
OP-IJEJ190194 1..15
20190 citationsauthor #1
The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer
201918 citationsauthor #13
Edinburgh Research Explorer Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk in the Breast Cancer Association Consortium
20191 citationsauthor #1
Abstract 1689: Comparative whole genome analyses of breast cancer aromatase inhibitor resistance models
20190 citationsauthor #6
Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1
201955 citationsauthor #8
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
2019114 citationsauthor #26
Genome-wide association study of germline variants and breast cancer-specific mortality
201955 citationsauthor #26
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
2019313 citationsauthor #37
Tamoxifen Pharmacogenetics and Metabolism: The Same Is Not the Same.
201917 citationsauthor #1
Two truncating variants in FANCC and breast cancer risk
20197 citationsauthor #21
Shared heritability and functional enrichment across six solid cancers
201994 citationsauthor #41
Abstract 464: Gene expression signatures for the prediction of endocrine treatment outcome in early-stage luminal breast cancer patients
20190 citationsauthor #11
Edinburgh Research Explorer Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk in the Breast Cancer Association Consortium
20190 citationsauthor #1
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
2019153 citationsauthor #47
Polymorphisms in the UBC 9 and PIAS 3 genes of the SUMO-conjugating system and breast cancer risk
20190 citationsauthor #8
Common breast cancer risk loci predispose to distinct tumor subtypes
20197 citationsauthor #25
Identification of nine new susceptibility loci for endometrial cancer
2018235 citationsauthor #14
Endocrine treatment of breast cancer: current concepts to predict and prevent relapse
20180 citationsauthor #1
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
20180 citationsauthor #9
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
2018887 citationsauthor #35
2017 Reviewer Acknowledgment
20180 citationsauthor #86
Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses
201879 citationsauthor #62
Abstract 3432: Evolving genomes of breast cancer aromatase inhibitor resistance models
20182 citationsauthor #5
Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem.
20188 citationsauthor #8
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
201818 citationsauthor #35
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.
201896 citationsauthor #24
Abstract 3425: Exome-sequencing derived mutations of endocrine treated ER-positive early breast cancer
20180 citationsauthor #7
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
2018281 citationsauthor #9
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)
20181 citationsauthor #152
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
201896 citationsauthor #34
Identification of nine new susceptibility loci for endometrial cancer
2018235 citationsauthor #16
Identification of nine new susceptibility loci for endometrial cancer
2018235 citationsauthor #15
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
2018208 citationsauthor #33
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
201752 citationsauthor #13
Tamoxifen pharmacogenomics of breast cancer: The controversy and way forward
20170 citationsauthor #1
Abstract 474: Estrogen-responsive miRNAs as modulators of E2-induced apoptosis in AI-resistant breast cancer
20172 citationsauthor #6
The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes
20170 citationsauthor #8
Association analysis identifies 65 new breast cancer risk loci
20171,295 citationsauthor #53
Edinburgh Research Explorer Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
20170 citationsauthor #18
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
20173 citationsauthor #15
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
201749 citationsauthor #15
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.
201781 citationsauthor #29
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.
201781 citationsauthor #28
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.
201781 citationsauthor #27
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017361 citationsauthor #66
Genomic analyses identify hundreds of variants associated with age at menarche and 1 support a role for puberty timing in cancer risk 2
20170 citationsauthor #56
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
2017499 citationsauthor #50
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
201721 citationsauthor #12
SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer
201740 citationsauthor #12
Abstract 5033: Optimized CYP2D6 phenotype assignment for plasma endoxifen prediction in breast cancer patients treated with tamoxifen
20170 citationsauthor #6
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
201715 citationsauthor #34

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT